StockNews.AI
BRKR
StockNews.AI
125 days

Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring

1. Bruker Corporation invests in RECIPE Chemicals + Instruments, a European diagnostic provider. 2. RECIPE offers vendor-agnostic therapeutic drug monitoring and diagnostic kits.

2m saved
Insight
Article

FAQ

Why Bullish?

This investment potentially enhances BRKR's diagnostic capabilities, similar to past strategic acquisitions that boosted growth.

How important is it?

The investment could lead to significant revenue growth and market presence, indicating a strong strategic move.

Why Long Term?

The acquisition positions BRKR for sustained growth in a booming diagnostics market, reminiscent of its prior expansions.

Related Companies

ILMNTMOPDCO
MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays. Financial details of the transaction were not disclosed. RECIPE has over 60 employees and continues to operate under the leadership of Managing Director Dr. Gerno.

Related News